These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3915951)

  • 1. Cholinergic markers in the early diagnosis of Alzheimer's disease.
    Jenden DJ
    Bull Clin Neurosci; 1985; 50():49-52. PubMed ID: 3915951
    [No Abstract]   [Full Text] [Related]  

  • 2. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease and the new neuroscience.
    Wortis J
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract]   [Full Text] [Related]  

  • 4. Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data.
    Sarter M; Bruno JP
    Ann Neurol; 2002 Sep; 52(3):384-5. PubMed ID: 12205659
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
    Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
    N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of cholinergic deficits in "pure" vascular dementia.
    Tomimoto H; Ohtani R; Ihara M
    Neurology; 2005 Jul; 65(1):179; author reply 179. PubMed ID: 16009926
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
    Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.
    Mann DM; Yates PO
    J Neurol Neurosurg Psychiatry; 1982 Oct; 45(10):936. PubMed ID: 7143014
    [No Abstract]   [Full Text] [Related]  

  • 13. Pro- and anti-apoptotic evidence for cholinergic denervation and hippocampal sympathetic ingrowth in rat dorsal hippocampus.
    Harrell LE; Parsons DS; Kolasa K
    Exp Neurol; 2005 Jul; 194(1):182-90. PubMed ID: 15899255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
    Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ
    Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: biological diagnosis.
    Ebinger G; Herregodts P; Michotte Y; Vanderheyden P; Vauqelin G
    Acta Neurol Belg; 1989; 89(3-4):132-4. PubMed ID: 2516958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological markers and the cholinergic hypothesis in Alzheimer's disease.
    Nordberg A
    Acta Neurol Scand Suppl; 1992; 139():54-8. PubMed ID: 1414270
    [No Abstract]   [Full Text] [Related]  

  • 18. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.
    Perry RH; Candy JM; Perry EK; Irving D; Blessed G; Fairbairn AF; Tomlinson BE
    Neurosci Lett; 1982 Dec; 33(3):311-5. PubMed ID: 7162693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.